How can the smoking cessation process be strengthened?
In a successful cessation plan, the daily amount of cigarettes, the time of the first cigarette, previous attempts, triggers, stress-sleep patterns, and the individual’s health status are evaluated together. Planning the quit date, environmental adjustments, and alternative behaviors for difficult moments in advance can facilitate the process.
Human study on bioresonance
In a prospective, placebo-controlled, and double-blind pilot study published in 2014, 190 cigarette smokers were divided into bioresonance and placebo groups. Smoking cessation rates at 1-week, 2-week, 1-month, and 1-year follow-ups were reported to be higher in the active bioresonance group compared to the placebo group. The one-year success rate was reported as 28.6% in the active group and 16.1% in the placebo group; no treatment-related adverse effects were reported in the study.
This study provides controlled human data supporting further research into bioresonance as a supportive option in the smoking cessation process. The World Health Organization 2024 guideline indicates that evidence is not yet sufficient to form a recommendation for or against traditional and complementary methods as a whole; if these methods are used, it recommends integrating them into a comprehensive cessation approach that includes behavioral support and/or pharmacotherapy.
How can bioresonance be used in the plan?
When the application is preferred, targets can be measurable areas such as nicotine cravings, responses to triggers, stress, and the sustainability of cessation behavior. Rather than accepting the outcome of the session alone as the sole criterion of success, smoke-free days, relapses, and situations where the person struggles are monitored regularly.
Behavioral and pharmacological support
Behavioral counseling, nicotine replacement therapies, and, in eligible individuals, pharmacological options such as varenicline, bupropion, or cytisine can increase cessation success. Bioresonance can be addressed not as a competitor to these options, but as a complementary support that can be evaluated within a comprehensive plan according to the individual’s preferences and needs.
Our approach in our Bodrum clinic
We evaluate the level of nicotine dependence, daily triggers, sleep and stress burden, and previous quit experiences together. When bioresonance is preferred, we integrate it with behavioral support and, where necessary, pharmacological options, and regularly monitor the outcome.
References
- Pihtili A, et al. Evidence for the efficacy of a bioresonance method in smoking cessation: a pilot study. Forsch Komplementmed. 2014;21(4):239-245. PMID: 25231565.
- World Health Organization. Clinical treatment guideline for tobacco cessation in adults. 2024.
